Evaluation of three brands of rapid tests against blood samples for the detection of antibodies against HIV

Abstract

One of the important factors to reduce the spread of the human immunodeficiency virus (HIV) in Peru is the accessibility of diagnosis through rapid tests (RP), which are applied even in the most remote communities. However, during the five years 2011 - 2015, health establishments acquired and used more than 10 different brands, generating confusion in applying the methodology described in the inserts and consequently erroneous results (false positives and false negatives).